Acceleron Pharma Inc Net debt/EBITDA
¿Qué es el Net debt/EBITDA de Acceleron Pharma Inc?
El Net debt/EBITDA de Acceleron Pharma Inc es 10.60
¿Cuál es la definición de Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA de compañías en Sector Health Care en NASDAQ en comparadas con Acceleron Pharma Inc
¿Qué hace Acceleron Pharma Inc?
Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Acceleron's leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair.
Empresas con net debt/ebitda similar a Acceleron Pharma Inc
- GGL Resources tiene Net debt/EBITDA de 10.59
- T-Mobile US tiene Net debt/EBITDA de 10.59
- WorleyParsons tiene Net debt/EBITDA de 10.59
- WorleyParsons tiene Net debt/EBITDA de 10.59
- Colfax Corp tiene Net debt/EBITDA de 10.59
- The Cooper Companies tiene Net debt/EBITDA de 10.59
- Acceleron Pharma Inc tiene Net debt/EBITDA de 10.60
- Faurecia S.E tiene Net debt/EBITDA de 10.60
- Kellogg tiene Net debt/EBITDA de 10.61
- Saputo tiene Net debt/EBITDA de 10.61
- Aon plc tiene Net debt/EBITDA de 10.62
- Olema Pharmaceuticals tiene Net debt/EBITDA de 10.62
- RealPage tiene Net debt/EBITDA de 10.63